Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2021

Open Access 01-12-2021 | Pneumonia | Case report

Mechanical thrombectomy of COVID-19 DVT with congenital heart disease leading to phlegmasia cerulea dolens: a case report

Authors: Neema Jamshidi, Weiyi Tan, Dingle Foote, Leigh Reardon, Gentian Lluri, Jamil Aboulhosn, John Moriarty, Jeannette Lin

Published in: BMC Cardiovascular Disorders | Issue 1/2021

Login to get access

Abstract

Background

COVID-19 and Fontan physiology have each been associated with an elevated risk of venous thromboembolism (VTE), however little is known about the risks and potential consequences of having both.

Case presentation

A 51 year old male with tricuspid atresia status post Fontan and extracardiac Glenn shunt, atrial flutter, and sinus sick syndrome presented with phlegmasia cerulea dolens (PCD) of the left lower extremity in spite of supratherapeutic INR in the context of symptomatic COVID-10 pneumonia. He was treated with single session, catheter directed mechanical thrombectomy that was well-tolerated.

Conclusions

This report of acute PCD despite therapeutic anticoagulation with a Vitamin K antagonist, managed with emergent mechanical thrombectomy, calls to attention the importance of altered flow dynamics in COVID positive patients with Fontan circulation that may compound these independent risk factors for developing deep venous thrombosis with the potential for even higher morbidity.
Literature
1.
go back to reference Morales MH, Leigh CL, Simon EL. COVID-19 infection with extensive thrombosis: a case of phlegmasia cerulea dolens. Am J Emerg Med. 2020;38(9):1978 e1–e3. Morales MH, Leigh CL, Simon EL. COVID-19 infection with extensive thrombosis: a case of phlegmasia cerulea dolens. Am J Emerg Med. 2020;38(9):1978 e1–e3.
2.
go back to reference Middeldorp S, Coppens M, van Haaps TF, et al. Incidence of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost. 2020;18:1995–2002.CrossRef Middeldorp S, Coppens M, van Haaps TF, et al. Incidence of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost. 2020;18:1995–2002.CrossRef
3.
go back to reference Visveswaran GK, Morparia K, Narang S et al. Severe acute respiratory syndrome coronavirus 2 infection and thrombosis: phlegmasia cerulea dolens presenting with venous gangrene in a child. J Pediatr. 2020;226:281–4 e1. Visveswaran GK, Morparia K, Narang S et al. Severe acute respiratory syndrome coronavirus 2 infection and thrombosis: phlegmasia cerulea dolens presenting with venous gangrene in a child. J Pediatr. 2020;226:281–4 e1.
4.
go back to reference Bamgboje A, Hong J, Mushiyev S, Pekler G. A 61-year-old man with SARS-CoV-2 infection and venous thrombosis presenting with painful swelling and gangrene of the lower limb consistent with phlegmasia cerulea dolens. Am J Case Rep. 2020;21:e928342.CrossRef Bamgboje A, Hong J, Mushiyev S, Pekler G. A 61-year-old man with SARS-CoV-2 infection and venous thrombosis presenting with painful swelling and gangrene of the lower limb consistent with phlegmasia cerulea dolens. Am J Case Rep. 2020;21:e928342.CrossRef
5.
go back to reference Chen S, Zhang D, Zheng T, Yu Y, Jiang J. DVT incidence and risk factors in critically ill patients with COVID-19. J Thromb Thrombolysis. 2021;51(1):33–9.CrossRef Chen S, Zhang D, Zheng T, Yu Y, Jiang J. DVT incidence and risk factors in critically ill patients with COVID-19. J Thromb Thrombolysis. 2021;51(1):33–9.CrossRef
6.
go back to reference Li L, Zhang W, Hu Y, et al. Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19: a randomized clinical trial. JAMA. 2020;324(5):460–70.CrossRef Li L, Zhang W, Hu Y, et al. Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19: a randomized clinical trial. JAMA. 2020;324(5):460–70.CrossRef
7.
go back to reference Oguzkurt L, Ozkan U, Demirturk OS, Gur S. Endovascular treatment of phlegmasia cerulea dolens with impending venous gangrene: manual aspiration thrombectomy as the first-line thrombus removal method. Cardiovasc Intervent Radiol. 2011;34:1214–21.CrossRef Oguzkurt L, Ozkan U, Demirturk OS, Gur S. Endovascular treatment of phlegmasia cerulea dolens with impending venous gangrene: manual aspiration thrombectomy as the first-line thrombus removal method. Cardiovasc Intervent Radiol. 2011;34:1214–21.CrossRef
8.
go back to reference Spagnolo P, Balestro E, Aliberti S, et al. Pulmonary fibrosis secondary to COVID-19: a call to arms? Lancet Respir Med. 2020;8(8):750–2.CrossRef Spagnolo P, Balestro E, Aliberti S, et al. Pulmonary fibrosis secondary to COVID-19: a call to arms? Lancet Respir Med. 2020;8(8):750–2.CrossRef
9.
go back to reference Gewillig M, Brown SC. The Fontan circulation after 45 years: update in physiology. Heart. 2016;102:1081–6.CrossRef Gewillig M, Brown SC. The Fontan circulation after 45 years: update in physiology. Heart. 2016;102:1081–6.CrossRef
10.
go back to reference Marrone C, Galasso G, Piccolo R, et al. Antiplatelet versus anticoagulation therapy after extracardiac conduit Fontan: a systematic review and meta-analysis. Pediatr Cardiol. 2011;32:32–9.CrossRef Marrone C, Galasso G, Piccolo R, et al. Antiplatelet versus anticoagulation therapy after extracardiac conduit Fontan: a systematic review and meta-analysis. Pediatr Cardiol. 2011;32:32–9.CrossRef
11.
go back to reference Fredenburg TB, Johnson TR, Cohen MD. The Fontan procedure: anatomy, complications, and manifestations of failure. Radiographics. 2011;31:453–63.CrossRef Fredenburg TB, Johnson TR, Cohen MD. The Fontan procedure: anatomy, complications, and manifestations of failure. Radiographics. 2011;31:453–63.CrossRef
12.
go back to reference Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020;135:2033–40.CrossRef Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020;135:2033–40.CrossRef
13.
go back to reference Mondal S, Quintili AL, Karamchandani K, Bose S. Thromboembolic disease in COVID-19 patients: a brief narrative review. J Intensive Care. 2020;8:70.CrossRef Mondal S, Quintili AL, Karamchandani K, Bose S. Thromboembolic disease in COVID-19 patients: a brief narrative review. J Intensive Care. 2020;8:70.CrossRef
14.
go back to reference Mumoli N, Invernizzi C, Luschi R, Carmignani G, Camaiti A, Cei M. Phlegmasia cerulea dolens. Circulation. 2012;125:1056–7.CrossRef Mumoli N, Invernizzi C, Luschi R, Carmignani G, Camaiti A, Cei M. Phlegmasia cerulea dolens. Circulation. 2012;125:1056–7.CrossRef
15.
go back to reference Hagberg E, Berlin OK, Renstrom P. Function after through-knee compared with below-knee and above-knee amputation. Prosthet Orthot Int. 1992;16:168–73.CrossRef Hagberg E, Berlin OK, Renstrom P. Function after through-knee compared with below-knee and above-knee amputation. Prosthet Orthot Int. 1992;16:168–73.CrossRef
Metadata
Title
Mechanical thrombectomy of COVID-19 DVT with congenital heart disease leading to phlegmasia cerulea dolens: a case report
Authors
Neema Jamshidi
Weiyi Tan
Dingle Foote
Leigh Reardon
Gentian Lluri
Jamil Aboulhosn
John Moriarty
Jeannette Lin
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2021
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-021-02403-w

Other articles of this Issue 1/2021

BMC Cardiovascular Disorders 1/2021 Go to the issue